Sage’s new antidepressant faces major setback in new study

Sage’s new antidepressant faces major setback in new study

STAT Plus: Sage’s new antidepressant faces major setback in new study

By MATTHEW HERPER AND ADAM FEUERSTEIN

APSTOCK

The medication, which aimed to treat depression more rapidly than existing drugs, failed its first large study in patients in major depression.

READ MORE